Highlights • Both Long COVID and ME/CFS patients have dysfunctional CD8 T-cells with severe deficiencies in production of IFNg and TNFa. • Immune deficiency and health improve on treatment with nebulized antioxidant, anti-pathogen and immune-modulatory agent. • Useful new biomarker, CD8 T-cell dysfunction, assists in diagnosis and tracking response to potential new treatments.
All Keywords
【저자키워드】 antioxidant, Long COVID, T cell exhaustion, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), immune dysregulation, nebulized, CD8 T-cell dysfunction, Inspiritol,
【저자키워드】 antioxidant, Long COVID, T cell exhaustion, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), immune dysregulation, nebulized, CD8 T-cell dysfunction, Inspiritol,